Elemental Enzymes, a St. Louis biotechnology firm, has obtained a patent for a natural peptide solution to treat citrus greening disease. The peptide solution, Vismax, is readying for commercialization and is expected to reach the market by 2022. Vismax has been developed and extensively field tested, says Brian Thompson, CEO of Elemental Enzymes. Thompson gave a presentation on Nov. 18 …